Drug intelligence / Profile preview

Qingjiang Hewei Granules

Development stage
Unknown
Lead developer
Heilongjiang ZBD Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Qingjiang Hewei Granules is an innovative Traditional Chinese Medicine (TCM) candidate developed by Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd. for the treatment of non-erosive gastroesophageal reflux disease (NERD). Classified as a Class 1.1 new TCM drug in China, it is specifically formulated to address the "liver and stomach heat" syndrome (肝胃郁热证), which is characterized by symptoms such as heartburn, acid regurgitation, and epigastric pain. The therapeutic approach of the granules is to clear heat, harmonize the stomach, and descend rebellious qi. By targeting these underlying TCM imbalances, the drug aims to alleviate the clinical symptoms of NERD and improve patient quality of life. It has advanced into Phase 3 clinical trials in China.

Brand names
Qingjiang Hewei Granules
Other names
清降和胃颗粒

Beyond the preview

Go deeper on Qingjiang Hewei Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingjiang Hewei Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call